Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other	7.60M	4.38M	9.40M	1.68M	675.42K
Other Growth	73.59%	-53.43%	459.80%	148.54%	-47.08%
Direct Selling	291.97M	288.86M	282.57M	251.74M	244.84M
Direct Selling Growth	1.08%	2.23%	12.25%	2.82%	11.95%
Distribution	25.87M	46.03M	43.16M	35.32M	40.00M
Distribution Growth	-43.80%	6.65%	22.18%	-11.68%	-44.34%
Government Procurement	90.93M	102.19M	87.59M	92.70M	84.93M
Government Procurement Growth	-11.02%	16.68%	-5.51%	9.15%	10.97%
Total	416.37M	441.46M	422.71M	381.44M	370.44M
Total Growth	-5.68%	4.43%	10.82%	2.97%	0.56%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	416.37M	441.46M	422.71M	385.77M	370.44M
China Growth	-5.68%	4.43%	9.58%	4.14%	0.53%
Total	416.37M	441.46M	422.71M	385.77M	370.44M
Total Growth	-5.68%	4.43%	9.58%	4.14%	0.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error